Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm no expert, again, but this looks like another technical breakout.
Well, I'm no expert, but to me, it looks like a technical breakout is occurring.
My job has been to move the decimal point over to the left in terms of the worth of this investment. It has also been to put quotation marks around the last word of the last sentence. So far, this has been a very successful move in terms of job performance for me. Very consistent.
I'm doubting that anything will change, but if it does, there is a lot of movement to the right for the decimal point to take the worth of this away from the asymptote approaching zero.
Please read and post the paragraph that starts with "Cyclo Therapeutics (OTCQB: CTDH) is a client of RedChip Companies, Inc..."
*********************
Thanks in advance.
Disclaimer: I am a shareholder.
What kind of genuinely helpful information are you trying to convey?
Agreed. Substantive posts only are welcomed!
you said...<<I guess some of these can be cut from the list almost immediately to narrow down likely manufacturers. >>
True, indeed.
Based on my experience following this company and losing several 10s of thousands of dollars in it, I would simply narrow that list by removing the below candidates:
- Air Tractor AT-802
- Allied Ag-Cat Productions Inc. G-164 Ag Cat
- Cessna A188B-300 AGtruck
- GippsAero iGA200 Fatman
- Kruk (owned by EADS) PZL-106
- Pacific Aerospace PAC Cresco 08-600
- Embraer EMB 202 Ipanema
- Thrush Aircraft 510G
What you will be left with is what I currently have from this.
Learn.
With regard to what is going on, I really have no idea and I really don't know enough to guess. I doubt BK very much, but what is going on, if anything, to sustain or maximize shareholder value, I can't guess. I am just waiting, like a lot of people, sanguine that this is a high risk situation.
I had no issue. Try another computer and/or accessing from a different network. Everything works fine for me.
Agree - a floater
10 year pullback
I have noticed an accumulation of sorts.
You appear to see this as empty. Others see it as a fraction full.
Until I see anything genuinely material, I agree with you.
crickets
I have not telephoned the company in years. I believe I emailed Dr. Tate a couple or three years ago. I never got a response. Since I bought most of this between $.07 and $.15, I have not been as diligent as many people on the these boards. Unless there is a run of big volume, it's simply not worth selling and knocking down the price. I also think that most bulletin boards stocks are huge gambles. Once in a while one hits a winner such as this one (has been so far). That said, if there is some new use for cyclodextrins that can be provided by this company at a significant cost advantage, then we will be seen as very undervalued.
I'm interested in anything that might have to do with broadening the revenue stream, including anything related to the peripheral sub-companies that Dr. Tate used to talk about in the videos and which were part of the website. One of the disadvantages of this company is what they described in most of their SEC filings and on the company website ("The majority of our revenues are from five to ten customers who have historically been repeat purchasers. "), simply that a relative few companies comprise a large portion of their revenue stream. So, a broadening of their revenue stream would be nice to hear about.
I'd be interested in their perspective on the competition, although I would take what they say with a grain of salt. In general, I'm taking a passive approach to this, and I'm pleased with the general direction (up). Thanks for asking. I appreciate your enthusiasm, but not everything I'm seeing develop is, at least to me, is viewable as a long-term positive. Hence, my recent post. Good luck to you as well.
I have to agree with your assessment.
By the way, at one point my financial advisor told me I owned more than 2% of this company, so I really would like there to be no competition or lame competition, but I do not think that is really the case with "V". Personally, I have about 700% gain in this but nonetheless will ride this out because of the low daily trading volume. I originally invested in this in part because of the potential for use of this technology in more common diseases, but that still appears to be a mixture of wishful thinking and "early to the scene" thinking. The fact is there is competition in the lysosomal storage disease world and this is a bulletin board company that is not communicating effectively or even as well as it once did.
There is no guaranteed success here. I know that some of us would appreciate better communication from the company, but so far the trend is the opposite.
IMSC should sue for triple damages, IMO
I really appreciate your posts!
One bad apple doesn't spoil the whole bunch.
Thank you for this useful information!
ThesPian, LOL
New CTDH video out...
Was there a buffalo in that scenario? Shagging? Shagged? Exiting stage left?
Same actions for me.
I have to agree here. I have been trying to find objective analysis in the posts to which you refer and often end up wondering what are the true meanings - or whether or not there is any depth.
At this point, after "investing" in many OTCs over the past 20 years (and I mean many, many), most are not nearly as consistent and up front as CTDH.
I do not, on the other hand however, want to know about the Florida weather...unless there is a potential to interfere with production or business.
Very good information on cyclodextrins and food use. The lipids info is one of the main reasons I originally invested in this company. Glycemic index reduction.
Donuts is also betting on dollars... Sorry, couldn't resist.
There is still not much to say. Volume is steadily picking up (to my eye), the price appreciation looks great, but without serious volume or direction from the company, we are just left to admire the nice appreciation of our portfolios which in truth means nothing with a still basically illiquid stock. I am not about to sell and crash this stock without any information to make a sound decision.
I have an idea about what i would like to see these products do, but there is no reason to promote capricious speculation.
Sorry, there are a lot of unintended potential bad consequences to this, and it is not a driver for moving this business entity forward.
I agree with the other poster.
Example of unintended bad consequence: any aid to business by compensated person seen as a conflict of interest.
I. too, wish this family well and agree that their story has helped expose the company to some new investors. But, that does not equate to the company becoming profitable or conducting their business efficiently,reaching new markets, or even finding new uses for cyclodextrins.
You have stated your position adequately, but not researched any nor delineated any specifics to potential plan, the details of which are basically not "doable". This you have left to others. If you have specifics that you would like to discuss with management, I suggest you do so, but I personally cannot support this in the context of building a business.
Disclosure: private shareholder (>500k shares), no relation to company, no relation to anyone in question. Just my opinion.
This week's podcast "News in Slow French" has a segment on powdered alcohol. LOL
Maybe that is why there is a great interest in Polish investment?
Werewolves of London.
I have to agree with your assessment.
I think he meant that he hoped the buyer did not run out of money. Also, boards are nicer to read if people do not assume or state other people's motivations.
New video about placement uploaded:
That is positive.
This company is going to be profitable and that is a good reason to invest in it.
The reason he mentioned in the video is why I am invested in it. I am waiting for the ENMD-like day. It may be, however, just pie in the sky and may never happen.
In the meantime, admission price is not steep and the company is running well and diversifying both their products and their customer base.
Slow and steady wins the race.
I agree with this. Whatever they gave to the previous PR firm was a waste of all our money.
You could just write it off as a 100% loss.
I can concur with that. Many have tangential comments just looking for that single point of contact. On one hand, though, it is nice for people to have a single focus for their frustrations. Rational thought and complex problems are a lot more taxing and time-consuming.